Cbl-c Antibody (01) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-06621JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2B Clone # 01
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Cbl-c (Accession#: AAH28915.1; Met1-Ala474).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Cbl-c Antibody (01) [Janelia Fluor® 669]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cbl-c
Alternate Names
Cas-Br-M (murine) ecotropic retroviral transforming sequence c, Cas-Br-M (murine) ectropic retroviral transforming sequence c, CBL3, CBL-3, CBL-SL, RING finger protein 57, RNF57SH3-binding protein CBL-3, SH3-binding protein CBL-C, signal transduction protein CBL-C
Gene Symbol
CBLC
Additional Cbl-c Products
Product Documents for Cbl-c Antibody (01) [Janelia Fluor® 669]
Product Specific Notices for Cbl-c Antibody (01) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...